#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>By report
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Background information for Achondroplasia (FGFR3) 2 Mutations, Fetal: Characteristics: Short stature with disproportionately short arms and legs, a large head, usually normal life span and intelligence; increased risk for death in infancy from compression of spinal cord and/or upper airway obstruction. Incidence: 1:25,000. Inheritance: Autosomal dominant; 80 percent arise from de novo mutations. Penetrance: 100 percent. Cause: Pathogenic FGFR3 gene mutation. Clinical Sensitivity: Two mutations, c.1138G>A and c.1138G>C, in the FGFR3 gene account for greater than 99 percent of cases. Methodology: PCR and fluorescent hybridization probes. Analytical Sensitivity and Specificity: Greater than 99 percent. Limitations: Mutations other than c.1138G>A and c.1138G>C will not be detected.
For quality assurance purposes, ARUP Laboratories will confirm the above result at no charge following delivery. Order Confirmation of Fetal Testing and include a copy of the original fetal report (or the mother's name and date of birth) with the test submission. Please contact an ARUP genetic counselor at (800) 242-2787 extension 2141 prior to specimen submission.
This test is performed pursuant to an agreement with Roche Molecular Systems, Inc
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
See Compliance Statement C: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
81401; Fetal Cell Contamination (FCC): 81265;
|
*ExistCPT>
|